Palbociclib in Real World Practice

Official Title

Polaris: Palbociclib In Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicentre Non-interventional Study

Summary:

This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.

Trial Description

Primary Outcome Measures:

  • Clinical outcome
  • Patient quality of life, as measured by EORTC QLQ-C30
  • Geriatric Assessments in patients equal to or greater than 70 years of age at enrollment, as assessed by G8 Screening Tool
  • Geriatric Assessments in patients equal to or greater than 70 years of age at enrollment, as assessed by Activities of Daily Living
  • Biomarker Assessment 
  • Biospecimen Retention:   Samples With DNA, blood

View this trial on ClinicalTrials.gov

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society